Novel protease inhibitors (PIs) containing macrocyclic components and 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane that are potent against multi-PI-resistant HIV-1 variants in vitro.

Source:http://linkedlifedata.com/resource/pubmed/id/20439612

Download in:

View as

General Info

PMID
20439612